Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 38 Schemes (39.22%)
Foreign Institutions
Held by 71 Foreign Institutions (9.59%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2026)
Net Profit:
-57 Million
Pharmaceuticals & Biotechnology
USD 1,331 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.01
-999,999.00%
2.75






